Neovascularization and Hematopoietic Stem Cells

Cell Biochemistry and Biophysics

Volumn 67, Issue 2, 2013, Pages 235-245

  Lu, Jingwei ^a   Pompili, Vincent J ^a   Das, Hiranmoy ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Hematopoietic stem cells; Hypoxia; Neovascularization; Neutrophils; Notch signaling

Indexed keywords

ANIMALIA;

SIGNAL PEPTIDE;

ANGIOGENESIS; ANIMAL; CELL HYPOXIA; CYTOLOGY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNITY; METABOLISM; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL HYPOXIA; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNITY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 84886591208     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9298-x     Document Type: Review

References (125)

1. Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., et al. (2009). Heart disease and stroke statistics-2009 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation, 119(3), 480-486.
2. Cha, K. S., Schwartz, R. S., & Henry, T. D. (2005). Myocardial angiogenesis protein growth factors. In R. J. Laham & D. S. Baim (Eds.), Contemporary cardiology: Angiogenesis and direct myocardial revasularization. Totowa, NJ: Humana Press Inc.
3. Mukherjee, D., Bhatt, D. L., Roe, M. T., Patel, V., & Ellis, S. G. (1999). Direct myocardial revascularization and angiogenesis-how many patients might be eligible? American Journal of Cardiology, 84(5), 598-600. A8.
4. Shah, P. B., Lotun, K., & Losordo, D. W. (2005). Gene therapy for angiogenesis in the treatment of cardiovascular and peripheral arterial disease. In R. J. Laham & D. S. Baim (Eds.), Contemporary cardiology: angiogenesis and direct myocardial revasularization. Totowa: Humana Press Inc.
5. Schaper, W., & Ito, W. D. (1996). Molecular mechanisms of coronary collateral vessel growth. Circulation Research, 79(5), 911-919.
6. Ware, J. A., & Simons, M. (1997). Angiogenesis in ischemic heart disease. Nature Medicine, 3(2), 158-164.
7. Folkman, J. (1998). Angiogenic therapy of the human heart. Circulation, 97(7), 628-629.
8. Das, H., George, J. C., Joseph, M., Das, M., Abdulhameed, N., Blitz, A., et al. (2009). Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. Plos One, 4(10), e7325.
9. Carmeliet, P. (2005). Angiogenesis in life, disease and medicine. Nature, 438(7070), 932-936.
10. Byrd, N., & Gradel, L. (2004). Hedgehog signaling in murine vasculogenesis and angiogenesis. Trends in Cardiovascular Medicine, 14(8), 308-313.
11. Pugh, C. W., & Ratcliffe, P. J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nature Medicine, 9(6), 677-684.
12. Egami, K., Murohara, T., Aoki, M., & Matsuishi, T. (2006). Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin. Journal of Leukocyte Biology, 79(5), 971-976.
13. Suchting, S., & Eichmann, A. (2009). Jagged gives endothelial tip cells an edge. Cell, 137(6), 988-990.
14. Phng, L. K., & Gerhardt, H. (2009). Angiogenesis: a team effort coordinated by notch. Developmental Cell, 16(2), 196-208.
15. Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., et al. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. Journal of Cell Biology, 161(6), 1163-1177.
16. Iruela-Arispe, M. L., & Davis, G. E. (2009). Cellular and molecular mechanisms of vascular lumen formation. Developmental Cell, 16(2), 222-231.
17. Blum, Y., Belting, H. G., Ellertsdottir, E., Herwig, L., Luders, F., & Affolter, M. (2008). Complex cell rearrangements during intersegmental vessel sprouting and vessel fusion in the zebrafish embryo. Developmental Biology, 316(2), 312-322.
18. Goetze, J. P., Gore, A., Moller, C. H., Steinbruchel, D. A., Rehfeld, J. F., & Nielsen, L. B., (2004). Acute myocardial hypoxia increases BNP gene expression. FASEB Journal, 18(12), 1928-1930.
19. Smith, L. M., Golub, A. S., & Pittman, R. N. (2002). Interstitial Po-2 determination by phosphorescence quenching microscopy. Microcirculation, 9(5), 389-395.
20. Fong, G. H. (2009). Regulation of angiogenesis by oxygen sensing mechanisms. Journal of Molecular Medicine, 87(6), 549-560.
21. Kaelin, W. G., & Ratcliffe, P. J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Molecular Cell, 30(4), 393-402.
22. Ramirez-Bergeron, D. L., Runge, A., Dahl, K. D. C., Fehling, H. J., Keller, G., & Simon, M. C. (2004). Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development, 131(18), 4623-4634.
23. Tillmanns, J., Rota, M., Hosoda, T., Misao, Y., Esposito, G., Gonzalez, A., et al. (2008). Formation of large coronary arteries by cardiac progenitor cells. Proceedings of the National Academy of Sciences of the United States of America, 105(5), 1668-1673.
24. Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegue, E., et al. (2008). HIF1 alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell, 13(3), 206-220.
25. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine, 10(8), 858-864.
26. Lee, S. P., Youn, S. W., Cho, H. J., Li, L., Kim, T. Y., Yook, H. S., et al. (2006). Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation, 114(2), 150-159.
27. Fraisl, P., Mazzone, M., Schmidt, T., & Carmeliet, P. (2009). Regulation of angiogenesis by oxygen and metabolism. Dev Cell, 16(2), 167-179.
28. Schumacher, B., Pecher, P., von Specht, B. U., & Stegmann, T. (1998). Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation, 97(7), 645-650.
29. Laham, R. J., Sellke, F. W., Edelman, E. R., Pearlman, J. D., Ware, J. A., Brown, D. L., et al. (1999). Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation, 100(18), 1865-1871.
30. Ruel, M., Laham, R. J., Parker, J. A., Post, M. J., Ware, J. A., Simons, M., et al. (2002). Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. Journal of Thoracic and Cardiovascular Surgery, 124(1), 28-34.
31. Laham, R. J., Chronos, N. A., Pike, M., Leimbach, M. E., Udelson, J. E., Pearlman, J. D., et al. (2000). Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. Journal of the American College of Cardiology, 36(7), 2132-2139.
32. Unger, E. F., Goncalves, L., Epstein, S. E., Chew, E. Y., Trapnell, C. B., Cannon, R. O., 3rd, et al. (2000). Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. American Journal of Cardiology, 85(12), 1414-1419.
33. Udelson, J. E., Dilsizian, V., Laham, R. J., Chronos, N., Vansant, J., Blais, M., et al. (2000). Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation, 102(14), 1605-1610.
34. Simons, M., Annex, B. H., Laham, R. J., Kleiman, N., Henry, T., Dauerman, H., et al. (2002). Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation, 105(7), 788-793.
35. Hendel, R. C., Henry, T. D., Rocha-Singh, K., Isner, J. M., Kereiakes, D. J., Giordano, F. J., et al. (2000). Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation, 101(2), 118-121.
36. Henry, T. D., Rocha-Singh, K., Isner, J. M., Kereiakes, D. J., Giordano, F. J., Simons, M., et al. (2001). Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. American Heart Journal, 142(5), 872-880.
37. Henry, T. D., Annex, B. H., McKendall, G. R., Azrin, M. A., Lopez, J. J., Giordano, F. J., et al. (2003). The VIVA trial: vascular endothelial growth factor in Ischemia for vascular angiogenesis. Circulation, 107(10), 1359-1365.
38. Seiler, C., Pohl, T., Wustmann, K., Hutter, D., Nicolet, P. A., Windecker, S., et al. (2001). Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation, 104(17), 2012-2017.
39. Pecher, P., & Schumacher, B. A. (2000). Angiogenesis in ischemic human myocardium: clinical results after 3 years. Annals of Thoracic Surgery, 69(5), 1414-1419.
40. Vale, P. R., Losordo, D. W., Milliken, C. E., McDonald, M. C., Gravelin, L. M., Curry, C. M., et al. (2001). Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation, 103(17), 2138-2143.
41. Losordo, D. W., Vale, P. R., Hendel, R. C., Milliken, C. E., Fortuin, F. D., Cummings, N., et al. (2002). Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation, 105(17), 2012-2018.
42. Grines, C. L., Watkins, M. W., Helmer, G., Penny, W., Brinker, J., Marmur, J. D., et al. (2002). Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation, 105(11), 1291-1297.
43. Grines, C. L., Watkins, M. W., Mahmarian, J. J., Iskandrian, A. E., Rade, J. J., Marrott, P., et al. (2003). A randomized double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. Journal of the American College of Cardiology, 42(8), 1339-1347.
44. Ruel, M., Beanlands, R. S., Lortie, M., Chan, V., Camack, N., deKemp, R. A., Suuronen, E. J., Rubens, F. D., DaSilva, J. N., Sellke, F. W., Stewart, D. J., & Mesana, T. G., (2008). Concomitant treatment with oral l-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the endothelial modulation in angiogenic therapy randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery, 135(4), 762-770, 770 e1.
45. Bikfalvi, A., & Bicknell, R. (2002). Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends in Pharmacological Sciences, 23(12), 576-582.
46. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., et al. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature, 376(6535), 62-66.
47. Shalaby, F., Ho, J., Stanford, W. L., Fischer, K. D., Schuh, A. C., Schwartz, L., et al. (1997). A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell, 89(6), 981-990.
48. Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C., & Keller, G. (1998). A common precursor for hematopoietic and endothelial cells. Development, 125(4), 725-732.
49. Chung, Y. S., Zhang, W. J., Arentson, E., Kingsley, P. D., Palis, J., & Choi, K. (2002). Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development, 129(23), 5511-5520.
50. Ema, M., & Rossant, J. (2003). Cell fate decisions in early blood vessel formation. Trends in Cardiovascular Medicine, 13(6), 254-259.
51. Ghabrial, A. S., & Krasnow, M. A. (2006). Social interactions among epithelial cells during tracheal branching morphogenesis. Nature, 441(7094), 746-749.
52. Bentley, K., Gerhardt, H., & Bates, P. A. (2008). Agent-based simulation of Notch-mediated tip cell selection in angiogenic sprout initialisation. Journal of Theoretical Biology, 250(1), 25-36.
53. Gille, H., Kowalski, J., Li, B., LeCouter, J., Moffat, B., Zioncheck, T. F., et al. (2001). Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)-a reassessment using novel receptor-specific vascular endothelial growth factor mutants. Journal of Biological Chemistry, 276(5), 3222-3230.
54. Roca, C., & Adams, R. H. (2007). Regulation of vascular morphogenesis by Notch signaling. Genes and Development, 21(20), 2511-2524.
55. Hellstrom, M., Phng, L. K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., et al. (2007). Dll4 signaling through Notch1 regulates formation of tip cells during angiogenesis. Nature, 445(7129), 776-780.
56. Suchting, S., Freitas, C., le Noble, F., Benedito, R., Breant, C., Duarte, A., et al. (2007). The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proceedings of the National Academy of Sciences of the United States of America, 104(9), 3225-3230.
57. Tammela, T., Zarkada, G., Wallgard, E., Murtomaki, A., Suchting, S., Wirzenius, M., et al. (2008). Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature, 454(7204), 656-660.
58. Leslie, J. D., Ariza-McNaughton, L., Bermange, A. L., McAdow, R., Johnson, S. L., & Lewis, J. (2007). Endothelial signaling by the Notch ligand Delta-like 4 restricts angiogenesis. Development, 134(5), 839-844.
59. Siekmann, A. F., & Lawson, N. D. (2007). Notch signaling limits angiogenic cell behaviour in developing zebrafish arteries. Nature, 445(7129), 781-784.
60. Siekmann, A. F., Covassin, L., & Lawson, N. D. (2008). Modulation of VEGF signaling output by the Notch pathway. Bioessays, 30(4), 303-313.
61. Dou, G. R., Wang, Y. C., Hu, X. B., Hou, L. H., Wang, C. M., Xu, J. F., et al. (2008). RBPJ the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice. FASEB Journal, 22(5), 1606-1617.
62. Liu, Z. J., Xiao, M., Balint, K., Soma, A., Pinnix, C. C., Capobianco, A. J., Velazquez, O. C., & Herlyn, M. (2006). Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3 K/Akt pathways and requires MAML1. FASEB Journal, 20(7), 1009-1011.
63. Noseda, M., Chang, L., McLean, G., Grim, J. E., Clurman, B. E., Smith, L. L., et al. (2004). Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Molecular and Cellular Biology, 24(20), 8813-8822.
64. Harrington, L. S., Sainson, R. C., Williams, C. K., Taylor, J. M., Shi, W., Li, J. L., et al. (2008). Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvascular Research, 75(2), 144-154.
65. Trindade, A., Kumar, S. R., Scehnet, J. S., Lopes-da-Costa, L., Becker, J., Jiang, W., et al. (2008). Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood, 112(5), 1720-1729.
66. Silvestre, J. S., Mallat, Z., Tedgui, A., & Levy, B. I. (2008). Post-ischaemic neovascularization and inflammation. Cardiovascular Research, 78(2), 242-249.
67. Heil, M., & Schaper, W. (2007). Insights into pathways of arteriogenesis. Current Pharmaceutical Biotechnology, 8(1), 35-42.
68. Heil, M., Ziegelhoeffer, T., Pipp, F., Kostin, S., Martin, S., Clauss, M., et al. (2002). Blood monocyte concentration is critical for enhancement of collateral artery growth. American Journal of Physiology-Heart and Circulatory Physiology, 283(6), H2411-H2419.
69. Capoccia, B. J., Shepherd, R. M., & Link, D. C. (2006). G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood, 108(7), 2438-2445.
70. Stabile, E., Burnett, M. S., Watkins, C., Kinnaird, T., Bachis, A., la Sala, A., et al. (2003). Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation, 108(2), 205-210.
71. Couffinhal, T., Silver, M., Kearney, M., Sullivan, A., Witzenbichler, B., Magner, M., et al. (1999). Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE(-/-) mice. Circulation, 99(24), 3188-3198.
72. Stabile, E., Kinnaird, T., la Sala, A., Hanson, S. K., Watkins, C., Campia, U., et al. (2006). CD8(+) T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4(+) mononuclear cells through the expression of interleukin-16. Circulation, 113(1), 118-124.
73. van Weel, V., Toes, R. E. M., Seghers, L., Deckers, M. M. L., de Vries, M. R., Eilers, P. H., et al. (2007). Natural killer cells and CD4(+) T-Cells modulate collateral artery development. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(11), 2310-2318.
74. Iba, O., Matsubara, H., Nozawa, Y., Fujiyama, S., Amano, K., Mori, Y., et al. (2002). Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation, 106(15), 2019-2025.
75. Griendling, K. K., & FitzGerald, G. A. (2003). Oxidative stress and cardiovascular injury-Part I: basic mechanisms and in vivo monitoring of ROS. Circulation, 108(16), 1912-1916.
76. Griendling, K. K., & FitzGerald, G. A. (2003). Oxidative stress and cardiovascular injury-Part II: animal and human studies. Circulation, 108(17), 2034-2040.
77. Li, J. M., & Shah, A. M. (2004). Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 287(5), R1014-R1030.
78. Yasuda, M., Ohzeki, Y., Shimizu, S., Naito, S., Ohtsuru, A., Yamamoto, T., et al. (1998). Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sciences, 64(4), 249-258.
79. Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., et al. (2004). JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell, 118(6), 781-794.
80. Guzy, R. D., & Schumacker, P. T. (2006). Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Experimental Physiology, 91(5), 807-819.
81. Ebrahimian, T. G., Heymes, C., You, D., Blanc-Brude, O., Mees, B., Waeckel, L., et al. (2006). NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. American Journal of Pathology, 169(2), 719-728.
82. Bayraktutan, U., Blayney, L., & Shah, A. M. (2000). Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 20(8), 1903-1911.
83. Duilio, C., Ambrosio, G., Kuppusamy, P., DiPaula, A., Becker, L. C., & Zweier, J. L. (2001). Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. American Journal of Physiology-Heart and Circulatory Physiolology, 280(6), H2649-H2657.
84. Golino, P., Ragni, M., Cirillo, P., Avvedimento, V. E., Feliciello, A., Esposito, N., et al. (1996). Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nature Medicine, 2(1), 35-40.
85. Harlan, J. M., Killen, P. D., Harker, L. A., Striker, G. E., & Wright, D. G. (1981). Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. Journal of Clinical Investigation, 68(6), 1394-1403.
86. May, A. E., Seizer, P., & Gawaz, M. (2008). Platelets: inflammatory firebugs of vascular walls. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(3), S5-S10.
87. Nierodzik, M. L., & Karpatkin, S. (2006). Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell, 10(5), 355-362.
88. De Paula, E. V., Nascimento, M. C. F., Ramos, C. D., Ozelo, M. C., Machado, T. F., Guillaumon, A. T., et al. (2006). Early in vivo anticoagulation inhibits the angiogenic response following hindlimb ischemia in a rodent model. Thrombosis and Haemostasis, 96(1), 68-72.
89. Rafii, S., & Lyden, D. (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nature Medicine, 9(6), 702-712.
90. Rajantie, I., Ilmonen, M., Alminaite, A., Ozerdem, U., Alitalo, K., & Salven, P. (2004). Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood, 104(7), 2084-2086.
91. Ziegelhoeffer, T., Fernandez, B., Kostin, S., Heil, M., Voswinckel, R., Helisch, A., et al. (2004). Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circulation Research, 94(2), 230-238.
92. Peters, B. A., Diaz, L. A., Polyak, K., Meszler, L., Romans, K., Guinan, E. C., et al. (2005). Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nature Medicine, 11(3), 261-262.
93. Hattori, K., Dias, S., Heissig, B., Hackett, N. R., Lyden, D., Tateno, M., et al. (2001). Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. Journal of Experimental Medicine, 193(9), 1005-1014.
94. Tepper, O. M., Galiano, R. D., Capla, J. M., Kalka, C., Gagne, P. J., Jacobowitz, G. R., et al. (2002). Human endothelial progenitor exhibit impaired proliferation, cells from type II diabetics adhesion, and incorporation into vascular structures. Circulation, 106(22), 2781-2786.
95. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., et al. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research, 85(3), 221-228.
96. Crosby, J. R., Kaminski, W. E., Schatteman, G., Martin, P. J., Raines, E. W., Seifert, R. A., et al. (2000). Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circulation Research, 87(9), 728-730.
97. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., et al. (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine, 5(4), 434-438.
98. Lin, Y., Weisdorf, D. J., Solovey, A., & Hebbel, R. P. (2000). Origins of circulating endothelial cells and endothelial outgrowth from blood. Journal of Clinical Investigation, 105(1), 71-77.
99. Aicher, A., Rentsch, M., Sasaki, K., Ellwart, J. W., Fandrich, F., Siebert, R., et al. (2007). Non bonemarrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circulation Research, 100(4), 581-589.
100. You, D., Waeckel, L., Ebrahimian, T. G., Blanc-Brude, O., Foubert, P., Barateau, V., et al. (2006). Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation, 114(4), 328-338.
101. Urbich, C., Aicher, A., Heeschen, C., Dernbach, E., Hofmann, W. K., Zeiher, A. M., et al. (2005). Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. Journal of Molecular and Cellular Cardiology, 39(5), 733-742.
102. Rehman, J., Li, J., Orschell, C. M., & March, K. L. (2003). Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107(8), 1164-1169.
103. Hur, J., Yoon, C. H., Kim, H. S., Choi, J. H., Kang, H. J., Hwang, K. K., et al. (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(2), 288-293.
104. Tordjman, R., Delaire, S., Plouet, J., Ting, S., Gaulard, P., Fichelson, S., et al. (2001). Erythroblasts are a source of angiogenic factors. Blood, 97(7), 1968-1974.
105. Huang, Y. Q., Li, J. J., & Karpatkin, S. (2000). Identification of a family of alternatively spliced mRNA species of angiopoietin-1. Blood, 95(6), 1993-1999.
106. Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell, 103(3), 481-490.
107. Grant, M. B., May, W. S., Caballero, S., Brown, G. A., Guthrie, S. M., Mames, R. N., et al. (2002). Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nature Medicine, 8(6), 607-612.
108. Bailey, A. S., Jiang, S. G., Afentoulis, M., Baumann, C. I., Schroeder, D. A., Olson, S. B., et al. (2004). Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood, 103(1), 13-19.
109. Takakura, N., Watanabe, T., Suenobu, S., Yamada, Y., Noda, T., Ito, Y., et al. (2000). A role for hematopoietic stem cells in promoting angiogenesis. Cell, 102(2), 199-209.
110. Carmeliet, P. (2003). Angiogenesis in health and disease. Nature Medicine, 9(6), 653-660.
111. Gehling, U. M., Ergun, S., Schumacher, U., Wagener, C., Pantel, K., Otte, M., et al. (2000). In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood, 95(10), 3106-3112.
112. Urbich, C., & Dimmeler, S. (2004). Endothelial progenitor cells-characterization and role in vascular biology. Circulation Research, 95(4), 343-353.
113. Nieda, M., Nicol, A., Denning-Kendall, P., Sweetenham, J., Bradley, B., & Hows, J. (1997). Endothelial cell precursors are normal components of human umbilical cord blood. British Journal Haematology, 98(3), 775-777.
114. Rookmaaker, M. B., Verhaar, M. C., Loomans, C. J., Verloop, R., Peters, E., Westerweel, P. E., et al. (2005). CD34+ cells home, proliferate, and participate in capillary formation, and in combination with CD34- cells enhance tube formation in a 3-dimensional matrix. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(9), 1843-1850.
115. Murohara, T., Ikeda, H., Duan, J., Shintani, S., Sasaki, K., Eguchi, H., et al. (2000). Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. Journal of Clinical Investigation, 105(11), 1527-1536.
116. Ma, N., Stamm, C., Kaminski, A., Li, W., Kleine, H. D., Muller-Hilke, B., et al. (2005). Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovascular Research, 66(1), 45-54.
117. Ma, N., Ladilov, Y., Moebius, J. M., Ong, L., Piechaczek, C., David, A., et al. (2006). Intramyocardial delivery of human CD133 + cells in a SCID mouse cryoinjury model: bone marrow vs. cord blood-derived cells. Cardiovascular Research, 71(1), 158-169.
118. Bababeygy, S. R., Cheshier, S. H., Hou, L. C., Higgins, D. M., Weissman, I. L., & Tse, V. C. (2008). Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture. Stem Cells and Development, 17(1), 11-18.
119. Das, H., Abdulhameed, N., Joseph, M., Sakthivel, R., Mao, H. Q., & Pompili, V. J. (2009). Ex vivo nanofiber expansion and genetic modification of human cord blood-derived progenitor/stem cells enhances vasculogenesis. Cell Transplantation, 18(3), 305-318.
120. Lu, J., Aggarwal, R., Pompili, V. J., & Das, H. (2010). A novel technology for hematopoietic stem cell expansion using combination of nanofiber and growth factors. Recent Patents on Nanotechnology, 4(2), 125-135.
121. Aggarwal, R., Pompili, V. J., & Das, H. (2010). Genetic modification of ex vivo expanded stem cells for clinical application. Frontiers in Bioscience, 15, 854-871.
122. Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. Journal of Clinical Investigation, 107(11), 1395-1402.
123. Rohde, D., Wickenhauser, C., Denecke, S., Stach, A., Lorenzen, J., Hansmann, M. L., et al. (1994). Cytokine release by human bone marrow cells: analysis at the single cell level. Virchows Archiv, 424(4), 389-395.
124. Bikfalvi, A., & Han, Z. C. (1994). Angiogenic factors are hematopoietic growth factors and vice versa. Leukemia, 8(3), 523-529.
125. Adams, R. H., & Alitalo, K. (2007). Molecular regulation of angiogenesis and lymphangiogenesis. Nature Reviews Molecular Cell Biology, 8(6), 464-478.